-
-
Pharma & Human Health -
Pharma & Human Health -
Pharma & Human Health -
Pharma & Human Health
Editor’s Choice
Editor's Choice
New standards in sensitivity and accuracy for microbiome research
Microbiome research promises to transform human health; however, until now the field has been held back by the challenges of translating microbiome data into novel treatments, ingredients, diagnostics, and other healthcare solutions. A number of […]
Editor's Choice
Integrating Microbiome and Dietary Data: Microbiome Data Congress 2023
The composition and metabolic output of the human gut microbiome is shaped by several environmental factors, an important one being diet. To better understand the relationship between diet and microbiome function researchers must develop methods […]
Editor's Choice
Distinguishing Strains in Microbiome Samples: Considerations and Challenges
Defining the term “strain” is a conscientious issue within the microbiome field. Broadly speaking, a bacterial strain is a sub-group within a species with unique characteristics such as genetic makeup, metabolism, and morphology. But standards […]
In Case you Missed it:
Pharma & Human Health
Anti-bacterial virus treated antibiotic resistant infections with 86.6% success rate
A new international study conducted by the Israeli Phage Therapy Center (IPTC) led by Prof. Ran Nir-Paz at Hadassah Hebrew University Medical Center and Prof. Ronen Hazan of the Faculty of Dental Medicine at The […]
Editor's Choice
Integrating Microbiome and Dietary Data: Microbiome Data Congress 2023
The composition and metabolic output of the human gut microbiome is shaped by several environmental factors, an important one being diet. To better understand the relationship between diet and microbiome function researchers must develop methods […]
Pharma & Human Health
New study asserts resB® Lung Support improves lung function through microbiome-mediated mechanisms along the gut-lung axis in asthmatic population
Asthma is a major cause of disability, poor quality of life world-wide and health resource utilization. The World Health Organisation (WHO) estimated that 262 million people suffered from asthma in 2019 and it caused 455 […]
Finance
Bloom Science Announces Positive Topline Data from a Phase 1 Clinical Trial
Bloom Science, Inc., a clinical-stage, central nervous system (CNS) company focused on discovering and developing breakthrough therapeutics that target the Gut-Brain Axis for neurological diseases, today announced positive results from its Phase 1 clinical study […]
Pharma & Human Health
A fungus gets comfortable: Aspergillus fumigatus adapts to life in humans and shapes their lung microbiome
Aspergillus fumigatus strains that infect humans have a significantly altered metabolism compared to other strains in the environment. At the same time, infection with the fungus leads to an apparent change in the human lung microbiome. […]
Pharma & Human Health
Multiple sclerosis: fateful immune cell activation in gut made visible
Multiple sclerosis (MS) is an inflammatory autoimmune disease of the central nervous system. It is triggered by certain T cells, which infiltrate the brain and spinal cord and attack the insulating myelin sheath around axons. […]
Pharma & Human Health
Engineered probiotic developed to treat multiple sclerosis
Brigham researchers are working on a new approach to target autoimmunity in the brain leverages designer bacteria to make treatment safer and more effective Researchers from Brigham and Women’s Hospital, a founding member of the Mass General […]
Finance
Bactolife Raises EUR 30 million in Series A Financing
Bactolife A/S (“Bactolife”), a bioindustrial company developing proprietary Binding ProteinsTM, which strengthen the gut microbiome of humans and animals with the aim of reducing the burden of gastrointestinal infections and anti-microbial resistance, today announced that […]
